ISSN: 2277-3657
DOI Prefix: 10.51847

International Journal of Pharmaceutical Research and Allied Sciences

About us

The International Journal of Pharmaceutical Research and Allied Sciences (IJPRAS) [ISSN: 2277-3657] is an international, open-access journal published quarterly. All submitted manuscripts undergo a double-blind peer-review process to support impartial and rigorous editorial assessment.

IJPRAS provides a scholarly platform for researchers, academics, healthcare professionals, and industry specialists to communicate research findings and informed perspectives. The journal publishes original research papers presenting methodologically sound and previously unpublished work, as well as critical review articles that examine and synthesize developments within clearly defined subjects.

Through open access publication, the journal seeks to make scientific knowledge available to readers worldwide and facilitate constructive academic exchange. IJPRAS is committed to the publication of clear, reliable, and relevant scholarship that can support further research, professional practice, and informed decision-making.

Aims and Scope

The International Journal of Pharmaceutical Research and Allied Sciences (IJPRAS) [ISSN: 2277-3657] is a comprehensive, open-access scholarly journal that follows a double-blind peer-review process.

Aim

The journal aims to advance theoretical, experimental, computational, and clinical knowledge in pharmaceutical research and allied sciences by publishing high-quality original research articles, reviews, and other scholarly contributions. It seeks to connect fundamental discoveries with pharmaceutical development, clinical application, and patient-centered care while promoting interdisciplinary and translational research across the pharmaceutical sciences.

Scope

The journal welcomes original research and review articles in the following areas:

1.      Pharmaceutical Sciences and Drug Development

o    Pharmaceutics, formulation science, and advanced pharmaceutical formulations, including solid, topical, parenteral, and novel drug delivery systems

o    Nano- and targeted drug delivery systems, biomaterials, and pharmaceutical nanotechnology

o    Medicinal chemistry, pharmacognosy, natural products, and drug discovery

o    Pharmacology, toxicology, pharmacovigilance, and drug safety

o    Pharmaceutical analysis, analytical chemistry, pharmaceutical technology, manufacturing, quality assurance, and regulatory affairs

o    Biopharmaceutics, clinical pharmacokinetics, pharmacodynamics, and PK/PD modelling

o    Biopharmaceuticals, biosimilars, and pharmaceutical biotechnology

2.      Computational and Precision Pharmaceutical Sciences

o    Pharmacoinformatics, cheminformatics, bioinformatics, computational biology, and computer-aided drug design

o    Quantitative structure–activity relationship (QSAR) modelling and molecular modelling

o    Molecular dynamics simulations, molecular docking, virtual screening, and related computational methods

o    Pharmacogenomics, precision pharmacotherapy, personalized medicine, and biomarker-guided treatment

o    Artificial intelligence, machine learning, and data-driven approaches relevant to drug discovery, development, and therapeutic decision-making

3.      Allied Biomedical and Health Sciences

o    Biotechnology, microbiology, biochemistry, molecular biology, pathology, and neurosciences

o    Biomaterial sciences, tissue engineering, and biomedical applications relevant to pharmaceuticals

o    Clinical pharmacy, pharmacotherapy, pharmacoepidemiology, and pharmaceutical care

o    Health outcomes research, pharmacoeconomics, real-world evidence, and evidence-based medicine

4.      Translational and Interdisciplinary Research

o    Translational pharmaceutical research connecting laboratory discoveries with preclinical studies, clinical development, and therapeutic applications

o    Interdisciplinary approaches to drug discovery, formulation development, delivery, evaluation, and clinical use

o    Emerging technologies and innovative methods in pharmaceutical and biomedical research

o    Sustainable pharmaceutical manufacturing, green chemistry, and environmental biotechnology

o    Bioremediation, pharmaceutical waste management, and environmental studies with direct relevance to pharmaceuticals

Announcement and Advertisement 

Announcements regarding scientific activities such as conferences, symposium, are published for free. Advertisements can be either published or placed on website as banners.

Publishing Schedule: 4 issues per year (January, April, July, October).

Top Articles
Impact of a Healthy Lifestyle on the Psychological Well-being of University Students
Written by Hanawi S. A.   Published on Issue 2 Vol 9, 2020
Health can influence eating habits and also mental and social well-being. This cross-sectional study was conducted to determine the relationship between healthy lifestyle and stress among 173 university students using Simple Lifestyle Indicator Questionnaire (SLIQ) and Depression, Anxiety and Stress Score-42 (DASS-42) to measure their emotional states of depression, anxiety and stress. The results indicated that 71.8% were categorized as having an unhealthy lifestyle and 28.2% an intermediate li Read More

Relationship between Learning Style and Academic Performance among the Generation Z Students in Kuala Lumpur
Written by Siti Aishah Hanawi   Published on Issue 3 Vol 11, 2022
Every student has a unique learning style. Their personalities are shaped by factors affecting their learning styles. Besides that, it is evident that students’ distinctive learning style has a significant impact on their academic success. A cross-sectional study was done to investigate the degree of association between students’ learning styles and academic achievement. This research was conducted in Kuala Lumpur, and the participants were first- to third-year biomedical science stu Read More

Exploring Recent Updates on Molecular Docking: Types, Method, Application, Limitation & Future Prospects
Written by Mahendra Kumar Sahu   Published on Issue 2 Vol 13, 2024
Molecular docking serves as a crucial computational tool in the realm of drug discovery and development, aimed at understanding the interactions between small molecules and target proteins. This study delves into the objective of elucidating the evolution of molecular docking techniques, their current applications, and potential future directions. Through a comprehensive review of the literature and analysis of recent advancements, this study provides insights into the methodologies employed in Read More

Digital Childhood: the Impact of Using Digital Technology on Children’s Health
Written by Nehad Ahmed Ibrahim Zahra   Published on Issue 3 Vol 8, 2019
Background and Objective: Digital media can be considered as an important ‎ element of life for today's children and adolescents since they spend a lot of time ‎ using it. This increased use of digital media is associated with poor behavior and ‎ health status. Society in general and practitioners in public health in particular ‎ should promote digital media use strategies through health education. This study is ‎ aimed at evaluating the impact of using digital technology Read More

Latest Articles
Interpreting Biosimilar Switching Across Single, Multiple, Biosimilar-to-Biosimilar, and Reverse Treatment Sequences
Written by Carlos Ramirez   Published on Issue 4 Vol 15, 2026
Biosimilar switching is often discussed as a single intervention, although reference-to-biosimilar, repeated reference–biosimilar alternation, biosimilar-to-biosimilar switching, and return to a previous product represent different exposure histories. Combining these sequences can make reassuring evidence appear more transferable than the underlying studies permit. To critically synthesize recent clinical and review-level evidence on biosimilar switching and identify which conclusions are direct Read More

Programmable Cells Are Emerging as Drug Factories with Context-Dependent Pharmacology
Written by Amira Khalil   Published on Issue 4 Vol 15, 2026
Programmable therapeutic cells challenge a central assumption of conventional pharmacology: that dose is administered as a chemically defined quantity whose subsequent exposure can be separated from the machinery that produced it. Engineered mammalian cells and microorganisms instead remain biologically active after administration. They may sense endogenous or environmental signals, change state, execute genetic logic, migrate or persist in selected compartments, and generate therapeutic molecul Read More

AI-Guided Bioprocess Control Should Optimize Critical Quality Attributes Before Productivity
Written by Sven Larsson   Published on Issue 4 Vol 15, 2026
Artificial intelligence is increasingly capable of extracting process state from multivariate bioprocess data, forecasting trajectories, and proposing or executing control actions. Yet an optimization system can be technically sophisticated while pursuing the wrong objective. In biopharmaceutical manufacturing, maximizing titer, throughput, or equipment utilization does not by itself establish preservation of product quality. This Systems Perspective argues that AI-enabled control should therefo Read More

Pharmaceutical Biotechnology Needs Digital Twins That Preserve Biological Uncertainty
Written by Thabo Nkosi   Published on Issue 4 Vol 15, 2026
Digital twins are increasingly positioned as enabling technologies for model-based pharmaceutical biotechnology, yet many proposed architectures treat biological uncertainty as a nuisance to be averaged away rather than as part of the state that must be represented. This distinction matters because a bioprocess may remain numerically predictable while its underlying cell population, model structure, sensor validity, or scale-dependent behavior changes in ways that alter the meaning of that predi Read More

Issue 1 Volume 16 (2027)